Releases Saturday 22 June 2002
No 7352 Volume 324

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).


(1)  BABYWALKERS DELAY INFANT DEVELOPMENT

(2)  NO LINK BETWEEN EPILEPSY AND
CRIMINALITY

(3)  SIMPLE GUIDE FOR SUNCREAMS WILL HELP
USERS

(4)  SLEEP ATTACKS FROM PARKINSON'S DRUGS
DO EXIST

(5)  CLINICAL SYMPTOMS MAY AID EARLY
DIAGNOSIS OF VARIANT CJD


 

(1)  BABYWALKERS DELAY INFANT DEVELOPMENT

(Locomotor milestones and babywalkers: cross sectional
study)
http://bmj.com/cgi/content/full/324/7352/1494

Babywalkers are associated with significant delay in
achieving normal locomotor milestones in infants, such as
crawling, standing, and walking, and should be
discouraged, concludes a study in this week's BMJ.

Researchers in Ireland surveyed parents of 190 normal
healthy infants (83 boys and 107 girls), born at term and
attending registered day care centres. They asked parents
to record the age at which their child reached various
developmental milestones including rolling over, sitting
alone, crawling, and walking alone.

Of the102 infants using babywalkers, achieving crawling,
standing alone, and walking alone occurred later than in the
other infants. However, babywalker use was not
associated with achieving sitting with support, sitting alone,
standing with support, and walking with support.

They found strong associations between the amount of
babywalker use and the extent of developmental delay.
For example, each aggregated 24 hours of babywalker use
was associated with a delay of 3.3 days in walking alone
and a delay of 3.7 days in standing alone.

This study provides additional evidence that babywalkers
are associated with significant delay in achieving normal
locomotor milestones, say the authors. The use of
babywalkers should be discouraged, they conclude.

Contacts:

Mary Garrett, Director, University College Dublin School
of Physiotherapy, Mater Hospital, Dublin, Ireland
Email:  m.garrett@ucd.ie
 

(2)  NO LINK BETWEEN EPILEPSY AND
CRIMINALITY

(Prevalence of epilepsy in prisoners)
http://bmj.com/cgi/content/full/324/7352/1495

It has long been believed that people with epilepsy are
particularly prone to violence and criminality, but a study in
this week's BMJ finds that epilepsy is no more common in
prisoners than in the general population.

Fazel and colleagues reviewed seven surveys based on
clinical interviews of 3,111 prisoners. All respondents
were sentenced inmates, with an average age of 29. Ninety
per cent were men, and 22% had been convicted of
violent offences.

Only about 1% of the prisoners reported a history of
chronic epilepsy. The prevalence rate in general
populations is also approximately 1% for men aged 25-35
years.

"These findings reinforce our conclusion that the available
evidence provides no good support for the alleged link
between epilepsy and criminality," conclude the authors.

Contact:

Seena Fazel, Research Fellow, Department of Psychiatry,
University of Oxford, Warneford Hospital, Oxford, UK
Email:  seena.fazel@psych.ox.ac.uk
 

(3)  SIMPLE GUIDE FOR SUNCREAMS WILL HELP
USERS

(Letter: Simple dosage guide for suncreams will help users)
http://bmj.com/cgi/content/full/324/7352/1526/a

Studies have shown that consumers apply much less
sunscreen than is required to achieve the sun protection
factor (SPF) stated on the product. In this week's BMJ,
researchers suggest a simple guide to ensure that people
are protected according to their expectations.

The "rule of nines" divides the body's surface area into 11
areas, each representing roughly 9% of the total.
Sunscreen can be applied to the recommended thickness if
two strips of sunscreen are squeezed out onto both the
index and middle fingers from the palmar crease to the
fingertips. The application of this "two fingers" of sunscreen
will provide a dose of the product that approximates to
that used during the laboratory determination of the SPF.

Users in fact are unlikely to be willing to cover themselves
or their families with such a copious layer of sunscreen and
would prefer to apply half this amount, say the authors.

They therefore suggest applying one finger of sunscreen,
with the corollary that the resultant protection would only
be about half that stated on the product. Users should then
be encouraged to reapply one finger's worth within half an
hour of the initial application in order to achieve optimum
protection, they conclude.

Contacts:

Steve Taylor, General Practitioner, Sunset Road Family
Doctors, Mairangi Bay, Auckland, New Zealand
Email: steve@dox.co.nz

or

Brian Diffey, Professor of Medical Physics, Regional
Medical Physics Department, Newcastle General Hospital,
Newcastle, UK
Email:  b.l.diffey@ncl.ac.uk
 

(4)  SLEEP ATTACKS FROM PARKINSON'S DRUGS
DO EXIST

(Sleep attacks in patients taking dopamine agonists:
review)
http://bmj.com/cgi/content/full/324/7352/1483

Car crashes in patients with Parkinson's disease have been
associated with sudden sleep attacks caused by dopamine
drugs, but the concept of sleep attacks, and their
connection with dopamine drugs, has been disputed.

In this week's BMJ, researchers in Austria aim to
determine whether sleep attacks do exist, whether
dopamine drugs are implicated, and whether attacks are
predictable, preventable, and treatable.

They reviewed 124 patients and found that sleep attacks
do exist in up to 30% of patients. They are associated with
all dopamine drugs and occur at both high and low doses
of the drugs. However, their prediction, prevention, and
treatment are yet to be solved.

Despite the potential danger from driving, experts believe
that sleep attacks are too infrequent to recommend that
patients taking dopamine drugs for Parkinson's disease
stop driving, say the authors. Recommendations for
driving, other than informing patients of a potential risk,
should be made with caution until more data are available,
they conclude.

Contact:

Carl Nikolaus Homann, Head of Department and Medical
Superintendent, Klinik Maria Theresia Hospital for
Neurological and Orthopedic Rehabilitation, Bad
Radkersburg, Austria
Email:  nik.homann@klinik-maria-theresia.at
 

(5)  CLINICAL SYMPTOMS MAY AID EARLY
DIAGNOSIS OF VARIANT CJD

(First hundred cases of variant Creutzfeldt-Jacob disease:
retrospective case note review of early psychiatric and
neurological features)
http://bmj.com/cgi/content/full/324/7352/1479

The possibility of a large epidemic of variant
Creutzfeldt-Jakob disease cannot be excluded, and
doctors may see patients who are worried about the
possibility of this diagnosis. A study in this week's BMJ
provides a comprehensive description of the early
psychiatric and neurological features of variant
Creutzfeldt-Jakob disease to aid early recognition of this
condition.

Researchers analysed the case notes of the first 100
patients diagnosed with variant Creutzfeldt-Jakob disease
in the UK.

They found that the early stages of variant
Creutzfeldt-Jakob disease are dominated by psychiatric
symptoms, such as dysphoria, withdrawal, anxiety, and
insomnia. A significant proportion of patients also exhibit
neurological symptoms within four months of clinical onset,
including poor memory, pain, sensory symptoms, and
unsteadiness of gait.

The early clinical features of variant Creutzfeldt-Jakob
disease described in this paper are consistent with previous
descriptions, say the authors. "We hope that the detailed
analysis of the early psychiatric and neurological features of
variant Creutzfeldt-Jakob disease in this paper may help
with early and accurate recognition of this condition."

Contact:

Richard Knight, Consultant Neurologist, National CJD
Surveillance Unit, Western General Hospital, Edinburgh,
Scotland
 


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice@bma.org.uk)
 
and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)
 




Access jobs at BMJ Careers
Whats new online at Student 

BMJ